S&P 500 — US Large Cap Index
FTSE 100 — UK Blue Chips
Euro Stoxx 50 — Eurozone Leaders
DAX 40 — German Equities
CAC 40 — French Market Index
Nikkei 225 — Japan Benchmark
Hang Seng — Hong Kong Index
Shanghai Composite — China Mainland
ASX 200 — Australian Market
TSX Composite — Canada Index
Nifty 50 — India Large Cap
STI Index — Singapore Market
KOSPI — South Korea Index
Bovespa — Brazil Equities
JSE Top 40 — South Africa Index
IPC Index — Mexico Market
The US government plans to impose a 100% tariff on generic drugs imported into the US beginning in August 2028. President Donald Trump said in a social media post Tuesday that all generic drugs being brought into the U.S. will continue to face a 0% tariff for two years starting August 1, after which the tariff rate will be raised to 100% for one year and to 200% thereafter. The phased schedule is intended to push generic drugmakers to move production onshore, with Trump calling the higher tariffs “a penalty” for companies that don’t build plants and facilities in the U.S. within the grace period. “This is done in order to RESHORE Generic Pharmaceutical Production into America, with a penalty to those Companies that decide not to build Plant and Equipment within the stated period of time given to them,” Trump said. Meanwhile, tariffs on patented and branded drugs would remain unchanged.
